Current and historical daily PE Ratio for ENZ (
Enzo Biochem Inc
) from 1990 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Enzo Biochem stock (ENZ) PE ratio as of Jun 08 2024 is 1.69.
More Details
Enzo Biochem Inc (ENZ) PE Ratio (TTM) Chart
Enzo Biochem Inc (ENZ) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1226
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Enzo Biochem PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 1.7 | 2024-04-05 | 1.9 |
| 2024-06-07 | 1.7 | 2024-04-04 | 1.9 |
| 2024-06-06 | 1.8 | 2024-04-03 | 1.9 |
| 2024-06-05 | 1.7 | 2024-04-02 | 1.9 |
| 2024-06-04 | 1.7 | 2024-04-01 | 1.9 |
| 2024-06-03 | 1.8 | 2024-03-28 | 1.9 |
| 2024-05-31 | 1.8 | 2024-03-27 | 1.9 |
| 2024-05-30 | 1.7 | 2024-03-26 | 1.9 |
| 2024-05-29 | 1.9 | 2024-03-25 | 1.9 |
| 2024-05-28 | 1.8 | 2024-03-22 | 1.9 |
| 2024-05-24 | 1.6 | 2024-03-21 | 1.8 |
| 2024-05-23 | 1.6 | 2024-03-20 | 1.8 |
| 2024-05-22 | 1.6 | 2024-03-19 | 1.8 |
| 2024-05-21 | 1.6 | 2024-03-18 | 1.9 |
| 2024-05-20 | 1.7 | 2024-03-15 | 1.8 |
| 2024-05-17 | 1.6 | 2024-03-14 | 1.9 |
| 2024-05-16 | 1.7 | 2024-03-13 | 1.8 |
| 2024-05-15 | 1.6 | 2024-03-12 | 1.9 |
| 2024-05-14 | 1.6 | 2024-03-11 | 2.0 |
| 2024-05-13 | 1.6 | 2024-03-08 | 2.0 |
| 2024-05-10 | 1.6 | 2024-03-07 | 2.0 |
| 2024-05-09 | 1.6 | 2024-03-06 | 2.0 |
| 2024-05-08 | 1.7 | 2024-03-05 | 2.0 |
| 2024-05-07 | 1.6 | 2024-03-04 | 2.0 |
| 2024-05-06 | 1.6 | 2024-03-01 | 2.0 |
| 2024-05-03 | 1.6 | 2024-02-29 | 2.0 |
| 2024-05-02 | 1.6 | 2024-02-28 | 2.0 |
| 2024-05-01 | 1.6 | 2024-02-27 | 2.0 |
| 2024-04-30 | 1.6 | 2024-02-26 | 2.0 |
| 2024-04-29 | 1.6 | 2024-02-23 | 2.1 |
| 2024-04-26 | 1.6 | 2024-02-22 | 2.0 |
| 2024-04-25 | 1.6 | 2024-02-21 | 2.0 |
| 2024-04-24 | 1.6 | 2024-02-20 | 2.0 |
| 2024-04-23 | 1.6 | 2024-02-16 | 2.0 |
| 2024-04-22 | 1.6 | 2024-02-15 | 2.0 |
| 2024-04-19 | 1.6 | 2024-02-14 | 2.1 |
| 2024-04-18 | 1.7 | 2024-02-13 | 2.0 |
| 2024-04-17 | 1.7 | 2024-02-12 | 2.0 |
| 2024-04-16 | 1.7 | 2024-02-09 | 2.0 |
| 2024-04-15 | 1.7 | 2024-02-08 | 2.0 |
| 2024-04-12 | 1.8 | 2024-02-07 | 1.9 |
| 2024-04-11 | 1.8 | 2024-02-06 | 1.9 |
| 2024-04-10 | 1.8 | 2024-02-05 | 1.9 |
| 2024-04-09 | 1.8 | 2024-02-02 | 1.9 |
| 2024-04-08 | 1.8 | 2024-02-01 | 1.9 |
Enzo Biochem Inc (ENZ) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Enzo Biochem Inc
NAICS : 621511
SIC : 8071
ISIN : US2941001024
Description
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers